Curbing spending on prescription drugs

Millions of patients suffering from painful and chronic medical conditions could find it easier to access effective and more affordable treatment options, as federal health officials take steps to grow a nascent prescription drug sector known as biosimilars. For Rhode Island, which spends a greater percentage of its gross state product on health care than

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber